• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microbiol Spectr . Diagnostic Performance of Six Rapid Antigen Tests for SARS-CoV-2

tetano

Editor, Senior Moderator
Microbiol Spectr


. 2022 Mar 16;e0235121.
doi: 10.1128/spectrum.02351-21. Online ahead of print.
Diagnostic Performance of Six Rapid Antigen Tests for SARS-CoV-2


Jessica Navero-Castillejos[SUP] 1 2 [/SUP], Climent Casals-Pascual[SUP] 1 2 [/SUP], Sofía Narváez[SUP] 1 [/SUP], Genoveva Cuesta[SUP] 1 [/SUP], Juan Carlos Hurtado[SUP] 1 2 [/SUP], Mariana Fernandez[SUP] 1 [/SUP], Mireia Navarro[SUP] 1 [/SUP], Aida Peiró-Mestres[SUP] 1 2 [/SUP], Ma Victoria Lasheras[SUP] 1 [/SUP], Patricia Rodriguez[SUP] 1 [/SUP], Andrea Pulgarín[SUP] 1 [/SUP], Ma Ángeles Marcos[SUP] 1 2 [/SUP], Jordi Vila[SUP] 1 2 [/SUP], Miguel Julián Martínez[SUP] 1 2 [/SUP]



Affiliations

Abstract

Microbiological diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a challenge. Although real-time reverse transcription PCR (RT-PCR) represents the gold standard method, strategies that allow rapid and simple diagnosis are necessary for the early identification of cases. In this study, we evaluated the diagnostic performance of six different commercial rapid antigen tests (Coronavirus antigen [Ag] rapid test cassette [Healgen Scientific, Houston, TX, USA], COVID-19 Ag FIA [Vircell, SD Biosensor Inc., Gyeonggi-do, Republic of Korea], Clinitest rapid COVID-19 antigen test [Siemens, Healthineers, Erlangen, Germany], SARS-CoV-2 rapid antigen test [SD Biosensor; Roche Diagnostics, Basel, Switzerland], Panbio COVID-19 Ag rapid test device [Abbott, Chicago, IL, USA], and SARS-CoV-2 test [MonLab, Barcelona, Spain]) in 130 nasopharyngeal swab samples tested previously by RT-PCR. The overall sensitivity of the rapid tests ranged from 65% to 79%, and the specificity was 100% for all of them. The sensitivity was higher for those samples with RT-PCR cycle threshold (C[SUB]T[/SUB]) values below 25 and those from patients presenting within the first week of symptoms. The Siemens test showed the highest sensitivity for patients with high viral loads while the Vircell test performed better than the rest for C[SUB]T[/SUB] values of ≥25. IMPORTANCE The rapid detection of people infected with SARS-CoV-2 is essential for a correct and effective control of the disease it causes. This process must be sensitive, fast, and simple, and it must be possible to carry out in any type of health center. Rapid antigen tests are the answer to this need. Knowing its ability to detect the virus in different stages of the disease is essential for a correct diagnosis, which is why this study has been carried out to evaluate the sensitivity and specificity of 6 different antigens tests in nasopharyngeal smear samples.

Keywords: SARS-CoV-2; diagnosis; rapid antigen test.
 
Back
Top Bottom